A study to assess serological response to the BNT162b2 mRNA or Chadox-Ncov-19 COVID-19 vaccine after first and second doses in plasma cell disorder patients
Latest Information Update: 03 Feb 2022
At a glance
- Drugs AZD 1222 (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Pharmacodynamics
Most Recent Events
- 03 Feb 2022 New trial record
- 14 Dec 2021 Results presented at the 63rd American Society of Hematology Annual Meeting and Exposition